PURPOSE: 3 For Life aims to increase hepatitis B virus (HBV) awareness and reduce the high prevalence of undiagnosed chronic HBV infection and susceptibility among Asian/Pacific Islander (API) adults. DESIGN: This pilot program offered low-cost HBV vaccination with free HBV testing targeted primarily at foreign-born Chinese adults. SETTING: Semimonthly screening and vaccination clinics were held in San Francisco, California, for 1 year. SUBJECTS: A total of 1206 adults accessed the program. INTERVENTION: Participants paid a discounted fee for a full vaccine series against HBV, hepatitis A virus (HAV), or both. Participants also provided blood samples for HBV serologic testing. Test results, recommendations, and appointment reminders were provided by mail. MEASURES: We compared the probability of completing a recommended vaccine series by HBV serologic status and sociodemographic characteristics. ANALYSIS: Proportions were compared using multivariate logistic regression models. RESULTS: Nine percent of adults were chronically infected with HBV, and 53% were unprotected. In the latter group, 85% completed the HBV vaccine series. The probability of completing a recommended hepatitis vaccine series was similar across most sociodemographic groups, with slightly higher completion rates among middle-aged and Chinese participants. CONCLUSIONS: Lessons learned from this pilot program have been used toward successful replication in other cities, demonstrating that 3 For Life is an accessible, affordable, reproducible, and sustainable model to increase HBV awareness, testing, and prevention among API adults.
PURPOSE: 3 For Life aims to increase hepatitis B virus (HBV) awareness and reduce the high prevalence of undiagnosed chronic HBV infection and susceptibility among Asian/Pacific Islander (API) adults. DESIGN: This pilot program offered low-cost HBV vaccination with free HBV testing targeted primarily at foreign-born Chinese adults. SETTING: Semimonthly screening and vaccination clinics were held in San Francisco, California, for 1 year. SUBJECTS: A total of 1206 adults accessed the program. INTERVENTION: Participants paid a discounted fee for a full vaccine series against HBV, hepatitis A virus (HAV), or both. Participants also provided blood samples for HBV serologic testing. Test results, recommendations, and appointment reminders were provided by mail. MEASURES: We compared the probability of completing a recommended vaccine series by HBV serologic status and sociodemographic characteristics. ANALYSIS: Proportions were compared using multivariate logistic regression models. RESULTS: Nine percent of adults were chronically infected with HBV, and 53% were unprotected. In the latter group, 85% completed the HBV vaccine series. The probability of completing a recommended hepatitis vaccine series was similar across most sociodemographic groups, with slightly higher completion rates among middle-aged and Chinese participants. CONCLUSIONS: Lessons learned from this pilot program have been used toward successful replication in other cities, demonstrating that 3 For Life is an accessible, affordable, reproducible, and sustainable model to increase HBV awareness, testing, and prevention among API adults.
Authors: Victoria M Taylor; Chong Teh; Wendy Lam; Elizabeth Acorda; Lin Li; Gloria Coronado; Yutaka Yasui; Christopher Bajdik; Gregory Hislop Journal: Can J Public Health Date: 2009 Nov-Dec
Authors: Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller Journal: J Natl Cancer Inst Date: 2013-07-22 Impact factor: 13.506